Melittin Inhibits Colorectal Cancer Growth and Metastasis by Ac-Tivating the Mitochondrial Apoptotic Pathway and Suppressing Epithelial–Mesenchymal Transition and Angiogenesis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111686 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kangli Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Melitten, Colorectal Neoplasms, Epithelial-Mesenchymal Transition, Apoptosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Modern Agroindustry Technology Research System from the Ministry of Agriculture of China.
Abstract (Originalsprache)
Melittin has previously been found to have a positive effect on colorectal cancer (CRC) treatment, one of the most difficult-to-treat malignancies, but the mechanism by which this effect occurs remains unclear. We evaluated melittin’s pro-apoptotic and anti-metastatic effects on CRC in vitro and in vivo. The results showed that melittin-induced mitochondrial ROS bursts decreased ΔΨm, inhibited Bcl-2 expression, and increased Bax expression in both cells and tumor tissues. This led to increased mitochondrial membrane permeability and the release of pro-apoptotic factors, particularly the high expression of Cytochrome C, initiating the apoptosis program. Additionally, through wound-healing and transwell assays, melittin inhibited the migration and invasion of CRC cells. In vivo, the anti-metastatic effect of melittin was also verified in a lung metastasis mouse model. Western blotting and immunohistochemistry analysis indicated that melittin suppressed the expression of MMPs and regulated the expression of crucial EMT markers and related transcription factors, thereby inhibiting EMT. Furthermore, the melittin disrupts neovascularization, ultimately inhibiting the metastasis of CRC. In conclusion, melittin exerts anti-CRC effects by promoting apoptosis and inhibiting metastasis, providing a theoretical basis for further research on melittin as a targeted therapeutic agent for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Förderung
- Modern Agroindustry Technology Research System from the Ministry of Agriculture of China
Zitieren
APA
Wang, K., Tao, L., Zhu, M., Yu, X., Lu, Y., Yuan, B., & Hu, F. (2024). Melittin Inhibits Colorectal Cancer Growth and Metastasis by Ac-Tivating the Mitochondrial Apoptotic Pathway and Suppressing Epithelial–Mesenchymal Transition and Angiogenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111686
Vancouver
Wang K, Tao L, Zhu M, Yu X, Lu Y, Yuan B, et al. Melittin Inhibits Colorectal Cancer Growth and Metastasis by Ac-Tivating the Mitochondrial Apoptotic Pathway and Suppressing Epithelial–Mesenchymal Transition and Angiogenesis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111686
BibTeX
@article{Wang2024,
author = {Wang, Kangli and Tao, Lingchen and Zhu, Meifei and Yu, Xinyu and Lu, Yuanyuan and Yuan, Bin and Hu, Fuliang},
title = {Melittin Inhibits Colorectal Cancer Growth and Metastasis by Ac-Tivating the Mitochondrial Apoptotic Pathway and Suppressing Epithelial–Mesenchymal Transition and Angiogenesis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111686}
}
EUVIMED